Out today for STAT subscribers, Allison DeAngelis has a fascinating profile of Steve Jobs' son, Reed, and his grand ambitions in biotech. It's worth your time: www.statnews.com/2023/12/12/r...

With big ambition — and a family name to match — Reed Jobs charts his own course in biotech

With big ambition — and a family name to match — Reed Jobs, the son of Steve Jobs, is charting his own course in biotech.

Between a rock & a hard place: New CRISPR-based therapies hold the promise of pain-free life for people with sickle cell disease. But the treatment can also lead to infertility, creating a difficult choice, as @mmolteni.bsky.socialwww.statnews.com/2023/12/06/s...

1. A flu 🧵 The season is picking up steam, specifically in the southern parts of the US. Louisiana is reporting that 19.3% of people tested for flu are positive for it — that getting into full-on flu season range. Nationally the rate is only 6.2%. From CDC's FluView. www.cdc.gov/flu/weekly/i...

With the FDA poised to approve exa-cel any day now, this smart story from my colleague Jason Mast on how sickle cell became the first “CRISPR’d” disease is an instructive look at both the future of treating the disease and for where gene editing goes next. www.statnews.com/2023/12/04/s...

How sickle cell became the first disease treated by CRISPR

Sickle cell disease, long ignored by drugmakers, turned out to be a perfect target for the flashy gene editing tool CRISPR. The question is, what next?